BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 22326749)

  • 1. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lecithin cholesterol acyltransferase deficiency protects from diet-induced insulin resistance and obesity--novel insights from mouse models.
    Ng DS
    Vitam Horm; 2013; 91():259-70. PubMed ID: 23374720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen S; Van Eck M
    J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.
    Tomimoto S; Tsujita M; Okazaki M; Usui S; Tada T; Fukutomi T; Ito S; Itoh M; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):394-400. PubMed ID: 11231919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
    Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
    Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
    Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
    Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
    Dobiásová M; Frohlich JJ
    Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of LCAT in Atherosclerosis.
    Ossoli A; Simonelli S; Vitali C; Franceschini G; Calabresi L
    J Atheroscler Thromb; 2016; 23(2):119-27. PubMed ID: 26607351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LCAT (lecithin:cholesterol acyltransferase)].
    Kinoshita M; Teramoto T
    Rinsho Byori; 2001 Nov; Suppl 116():125-30. PubMed ID: 11797372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.
    Roshan B; Ganda OP; Desilva R; Ganim RB; Ward E; Haessler SD; Polisecki EY; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2011; 5(6):493-9. PubMed ID: 22108153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional LCAT is not required for macrophage cholesterol efflux to human serum.
    Calabresi L; Favari E; Moleri E; Adorni MP; Pedrelli M; Costa S; Jessup W; Gelissen IC; Kovanen PT; Bernini F; Franceschini G
    Atherosclerosis; 2009 May; 204(1):141-6. PubMed ID: 18922527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.